EXTRAWELL PHARMACEUTICAL HLDGS financial statements, including revenue, expenses, profit, and loss
The total revenue of 858 for the last semiannual is 28.96 M HKD, and it's 3.93% lower compared to the previous semiannual. The net income of H2 23 is 74.78 M HKD.